PepBio
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- Undisclosed
Investors
- 1
About PepBio
, trading as PepBio, operates as a biopharmaceutical developer dedicated to building a large-scale library of natural active peptides. The company was co-founded by the professor of the Hunan University, CEO of Silver Valley Pharmaceuticals and research and development director of Jiuzitang. Lai Ern, the chief scientist of the company, was deputy director of Kunming Institute of Zoology, Chinese Academy of Sciences. The company developed and built a natural active peptide library, a high-throughput plus cloud computing screening platform and an AI artificial intelligence platform. These products enable peptide drug screening and development, and the development of innovative peptide drugs. The company has established a technical system for active peptides of animal venom, utilizing genome, transcriptome, peptidome and other multi-omics technologies to conduct histological analysis of toxic animal samples, and then collect highly active peptide sequences. The company generates revenue by doing R&D, and providing innovative peptide drugs and other related products.
Who invested in PepBio
1 investor across 1 round
See all investors in PepBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 19, 2025
Amount
Undisclosed
Investors
Questions about PepBio
Who invested in PepBio?
PepBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PepBio raised?
PepBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PepBio last raise money?
PepBio's most recent round on record is a Series A, in Dec 2025.
What does PepBio do?
, trading as PepBio, operates as a biopharmaceutical developer dedicated to building a large-scale library of natural active peptides.
Where is PepBio headquartered?
PepBio is headquartered in Chengdu, China.
Which VCs invest in companies like PepBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at PepBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PepBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.